Genialis
Boston
About Genialis
Genialis is a computational precision medicines company that develops a clinical biomarker discovery platform. It engages in unraveling complex biology to find new ways to address disease. Its platform defines, models, and validates actionable biomarkers and optimally positions novel drugs to accelerate translational research and clinical development. Genialis was established in 2015 in Boston, Massachusetts by Rafael Rosengarten.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $15.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2023)
- Website: genialis.com
- Phone: +1 617 237 0085
Industries & Categories
Bioinformatics, Biotechnology, Health Care, Medical, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/genialis-75923 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.